Abstract
The blood-brain barrier (BBB) exerts its central nervous system (CNS) protective function as it hinders the delivery of diagnostic and therapeutic agents to the brain. Gene therapy could be applied in conquering brain diseases such as neurodegenerative diseases and brain tumors by up- or down-regulating expression of diseased proteins. With the development of nanotechnology during the last thirty years, the nanocarriers for delivering drugs including gene medicines make it possible to transport drugs across the BBB. The nonviral nano-scaled gene delivery systems hold great promise for treating brain diseases due to their safety and convenience. Several brain targeting strategies, such as adsorptive- and receptor-mediated pathways have been developed to improve the brain targeting efficiency of non-viral gene delivery systems. In this review, the non-viral nanocarriers are focused for gene delivery and several possible strategies are discussed to achieve brain targeting effects. Finally, the applications of gene therapy in several brain diseases will be introduced.
Keywords: Blood-brain barrier, brain-targeting, gene therapy, nanoparticles, non-viral gene delivery, receptor-mediated endocytosis, central nervous system, herpes virus, lentiviruses, adeno-associated, immuno-genicity, viral cationic liposome, polymer vectors, lipoplexes, polyplexes, adsorptive-mediated endocytosis, Parkinson's disease, Alzheimer's disease, brain tumors, monocytes, Cationic Lipids, attenuation, hippocampus, Polyethylenimine (PEI), Polyamidoamine (PAMAM), red blood cells (RBCs), Adsorptive Mediated Endocytosis, HIV-1 Trans-Activating Transcriptional Activator, Antennapedia Peptide, Low Molecular Weight Protamine (LMWP), Transferrin Receptors, Lactoferrin (Lf) Receptors, Insulin Receptors, Acetylcholine Receptor, Low Density Lipoprotein (LDL) Receptor Family, Leptin Receptors, Dopamine, Neurotrophic Factors
Current Nanoscience
Title: Non-viral Gene Delivery and Therapeutics Targeting to Brain
Volume: 7 Issue: 1
Author(s): Yang Liu, Rongqin Huang and Chen Jiang
Affiliation:
Keywords: Blood-brain barrier, brain-targeting, gene therapy, nanoparticles, non-viral gene delivery, receptor-mediated endocytosis, central nervous system, herpes virus, lentiviruses, adeno-associated, immuno-genicity, viral cationic liposome, polymer vectors, lipoplexes, polyplexes, adsorptive-mediated endocytosis, Parkinson's disease, Alzheimer's disease, brain tumors, monocytes, Cationic Lipids, attenuation, hippocampus, Polyethylenimine (PEI), Polyamidoamine (PAMAM), red blood cells (RBCs), Adsorptive Mediated Endocytosis, HIV-1 Trans-Activating Transcriptional Activator, Antennapedia Peptide, Low Molecular Weight Protamine (LMWP), Transferrin Receptors, Lactoferrin (Lf) Receptors, Insulin Receptors, Acetylcholine Receptor, Low Density Lipoprotein (LDL) Receptor Family, Leptin Receptors, Dopamine, Neurotrophic Factors
Abstract: The blood-brain barrier (BBB) exerts its central nervous system (CNS) protective function as it hinders the delivery of diagnostic and therapeutic agents to the brain. Gene therapy could be applied in conquering brain diseases such as neurodegenerative diseases and brain tumors by up- or down-regulating expression of diseased proteins. With the development of nanotechnology during the last thirty years, the nanocarriers for delivering drugs including gene medicines make it possible to transport drugs across the BBB. The nonviral nano-scaled gene delivery systems hold great promise for treating brain diseases due to their safety and convenience. Several brain targeting strategies, such as adsorptive- and receptor-mediated pathways have been developed to improve the brain targeting efficiency of non-viral gene delivery systems. In this review, the non-viral nanocarriers are focused for gene delivery and several possible strategies are discussed to achieve brain targeting effects. Finally, the applications of gene therapy in several brain diseases will be introduced.
Export Options
About this article
Cite this article as:
Liu Yang, Huang Rongqin and Jiang Chen, Non-viral Gene Delivery and Therapeutics Targeting to Brain, Current Nanoscience 2011; 7 (1) . https://dx.doi.org/10.2174/157341311794480309
DOI https://dx.doi.org/10.2174/157341311794480309 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Advanced Inorganic Nanocomposites and their Emerging Applications
This special issue will highlight developments in the recent trends in the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc., and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis, as well as their ...read more
Advanced Nanotechnology in Forensic Science: Revolutionizing Fingerprint Identification and Crime Scene Analysis
This special issue aims to provide a comprehensive exploration of the innovative fusion between nanotechnology and forensic science. It aspires to bridge the gap between traditional investigative techniques and cutting-edge nanoscale applications, envisioning a paradigm shift in forensic analysis. By compiling the expertise of multidisciplinary experts, the book's objectives include ...read more
Graphene and 2D Materials for Energy Storage and Conversion.
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Nanopathology; A Promising Approach for Targeted Cancer Treatment
Cancer is the most challenging diseases in treatment worldwide. Recently, the nanotechnology opened the gate for targeting the cancer as a promising therapy. The small size and exceptional properties of nanoparticles give it several advantages for easily targeting of cancerous cells. Furthermore, this advantage allows them to easily penetrate deeply ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Opinion Paper: Selective Targeting of Liver Nodules. Present Situation and New Challenges to Enhance Indocyanine Green Captation from Colorectal Liver Metastases
Current Drug Delivery Gut Microbiota as an Emerging Therapeutic Avenue for the Treatment of Nonalcoholic Fatty Liver Disease
Current Pharmaceutical Design Fingolimod (FTY720) Reduces Cortical Infarction and Neurological Deficits During Ischemic Stroke Through Potential Maintenance of Microvascular Patency
Current Neurovascular Research Clinical Aspects of Melatonin in the Acute Coronary Syndrome
Current Vascular Pharmacology Transglutaminases as Possible Therapeutic Targets in Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) A<sub>3</sub> Adenosine Receptor: A Plausible Therapeutic Target for Cardio-Protection in Diabetes
Recent Patents on Cardiovascular Drug Discovery Urocortins: Putative Role in Cardiovascular Disease
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Editorial
Recent Patents on Drug Delivery & Formulation Non-peptide Antagonists and Agonists of the Bradykinin B2 Receptor
Current Medicinal Chemistry Pharmacological Treatments for Behavioral Addictions: From Behavioral Dimensions to the Research Domain Criteria Based Target
Current Psychopharmacology Role of Transglutaminase-Catalyzed Reactions in the Post-Translational Modifications of Proteins Responsible for Immunological Disorders
Inflammation & Allergy - Drug Targets (Discontinued) Mechanisms of Anticholinesterase Interference with Tau Aggregation Inhibitor Activity in a Tau-Transgenic Mouse Model
Current Alzheimer Research Pituitary Stem Cells Drop Their Mask
Current Stem Cell Research & Therapy Metabotropic Glutamate Receptors and Interacting Proteins in Epileptogenesis
Current Neuropharmacology Doppler Haemodynamics of Cerebral Venous Return
Current Neurovascular Research The Effects of Different Antioxidants on the Activity of Cerebrocortical MnSOD and Na,K-ATPase from post mortem Alzheimer’s Disease and Age-matched Normal Brains
Current Alzheimer Research Effect of Polyherbal Drug Majun Falasfa on the Transgenic Drosophila Model of Parkinson’s Disease
Current Traditional Medicine Role of Physical Exercise as Complementary Treatment for Epilepsy and other Brain Disorders
Current Pharmaceutical Design Mechanisms of Esophageal Protection, Gastroprotection and Ulcer Healing by Melatonin. Implications for the Therapeutic use of Melatonin in Gastroesophageal Reflux Disease (GERD) and Peptic Ulcer Disease
Current Pharmaceutical Design Plasticity and Therapeutic Potential of Mesenchymal Stem Cells in the Nervous System
Current Pharmaceutical Design